Symbols / AMV
AMV Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
News
RSS: Latest AMV news- Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus - TechStock² ue, 13 Jan 2026 08
- Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook - TechStock² Mon, 22 Dec 2025 08
- Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) - Business Wire hu, 20 Mar 2025 07
- Atlis Motor Vehicles shares see massive swings after unique path to public listing - The Business Journals Wed, 28 Sep 2022 07
- Atlis Motor Vehicles Stock: An EV Long Shot - Nanalyze hu, 29 Sep 2022 07
- Atlis Motor Opens for Trading - InvestorPlace ue, 27 Sep 2022 07
- Patria Group’s Financial Review for 2023 – preliminary data - Patria’s strong growth continued: net sales grew significantly, profitability improved and order stock developed strongly - patriagroup.com Fri, 09 Feb 2024 08
- CORRECTION – Atlis Motor Vehicles Shareholders Approve Reorganization to Holding Company, Nxu, Inc., and Omnibus Incentive Plan - Yahoo Finance Fri, 12 May 2023 07
- Atlis Motor Vehicles (NASDAQ: AMV) Down -94% Since IPO - Value The Markets Fri, 12 May 2023 07
- Atlis Motor Stock Falls Sharply After Surging More Than 700% Over 2 Days - Barron's Wed, 28 Sep 2022 07
- Alnylam changes analysis plan for key Amvuttra heart trial, jolting investors - Fierce Pharma hu, 15 Feb 2024 08
- Alnylam stock slides after “Alnylam 2030” plan, Amvuttra Q4 sales come up short - TechStock² Mon, 12 Jan 2026 08
- Double Vision - Archaeology Magazine Wed, 12 Jun 2024 05
- Atlis Motor Vehicles shares get a huge jolt on first day of Nasdaq trading - The Business Journals ue, 27 Sep 2022 07
- Micron News: Why Is MU Stock Up Today? - InvestorPlace Wed, 04 Jan 2023 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AMV
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|